A Review on Hematopoietic Stem Cell Treatment for Epilepsy

(E-pub Ahead of Print)

Author(s): Mohan Krishna Ghanta, Neha Merchant, L.V.K.S. Bhaskar*

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders


Become EABM
Become Reviewer
Call for Editor

Abstract:

Epilepsy responds to pharmacotherapy in its initial stages. The response of some forms of epilepsy like the refractory epilepsy is extremely low. Surgical management of epilepsy is associated with complications, which necessitates the search for novel and modern strategies for the treatment of epilepsy. Neuroprotection and neuronal regeneration are the major targets that must be accomplished by the new strategies. Hematopoietic stem cell (HSCs) therapy for epilepsy has shown promising results in pre-clinical studies with marginal clinical effects. This review explores the characteristics, mechanism of action, and clinical significance of HSCs therapy for the treatment of epilepsy.

Keywords: Neuroprotection, Neuronal regeneration, Antiepileptic property.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1871527320666210218085816
Price: $95

Article Metrics

PDF: 61